Status
Available
Call number
Publication
Pittsburgh, Pennsylvania : Oncology Nursing Society
ISBN
9781635930207
Description
Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice features 26 chapters examining multiple categories of cancer-care agents, including chemotherapy, immunotherapy, molecularly targeted agents, and hormone therapy.
Local notes
CLICK HERE TO VIEW EBOOK:
https://www.r2library.com/Resource/Title/1635930200
CONTENTS:
Table of Contents
Front Matter
Section I Professional Practice Considerations
Chapter 1: Professional Practice Considerations
Chapter 2: Ethical and Legal Issues
Chapter 3: Patient Education
Section II Cancer and Cancer Treatment
Chapter 4: Overview of Cancer and Cancer Treatment
Chapter 5: Clinical Trials and Drug Development
Section III Cancer Therapeutics
Chapter 6: Chemotherapy
Chapter 7: Hormone Therapy
Chapter 8: Targeted Therapy
Chapter 9: Principles of the Immune System
Chapter 10: Immunotherapy
Section IV Treatment Administration and Safety
Chapter 11: Administration Considerations
Chapter 12: Safe Handling of Hazardous Drugs
Chapter 13: Infusion-Related Complications
Section V Treatment-Related Complications
Chapter 14: Myelosuppression
Chapter 15: Gastrointestinal and Mucosal Toxicities
Chapter 16: Cardiovascular Toxicities
Chapter 17: Pulmonary Toxicities
Chapter 18: Hepatic Toxicities
Chapter 19: Genitourinary Toxicities
Chapter 20: Altered Sexual and Reproductive Functioning
Chapter 21: Cutaneous Toxicities and Alopecia
Chapter 22: Endocrine Toxicities
Chapter 23: Fatigue
Chapter 24: Neurologic Toxicities
Chapter 25: Ocular Toxicities
Section VI Post-treatment
Chapter 26: Post-treatment and Survivorship Care
https://www.r2library.com/Resource/Title/1635930200
CONTENTS:
Table of Contents
Front Matter
Section I Professional Practice Considerations
Chapter 1: Professional Practice Considerations
Chapter 2: Ethical and Legal Issues
Chapter 3: Patient Education
Section II Cancer and Cancer Treatment
Chapter 4: Overview of Cancer and Cancer Treatment
Chapter 5: Clinical Trials and Drug Development
Section III Cancer Therapeutics
Chapter 6: Chemotherapy
Chapter 7: Hormone Therapy
Chapter 8: Targeted Therapy
Chapter 9: Principles of the Immune System
Chapter 10: Immunotherapy
Section IV Treatment Administration and Safety
Chapter 11: Administration Considerations
Chapter 12: Safe Handling of Hazardous Drugs
Chapter 13: Infusion-Related Complications
Section V Treatment-Related Complications
Chapter 14: Myelosuppression
Chapter 15: Gastrointestinal and Mucosal Toxicities
Chapter 16: Cardiovascular Toxicities
Chapter 17: Pulmonary Toxicities
Chapter 18: Hepatic Toxicities
Chapter 19: Genitourinary Toxicities
Chapter 20: Altered Sexual and Reproductive Functioning
Chapter 21: Cutaneous Toxicities and Alopecia
Chapter 22: Endocrine Toxicities
Chapter 23: Fatigue
Chapter 24: Neurologic Toxicities
Chapter 25: Ocular Toxicities
Section VI Post-treatment
Chapter 26: Post-treatment and Survivorship Care